Zenapax
Overdosage & Contraindications
OVERDOSE
There have not been any reports of overdoses with ZENAPAX. A maximum tolerated dose has not been determined in patients. A dose of 1.5 mg/kg has been administered to bone marrow transplant recipients without any associated adverse events.
CONTRAINDICATIONS
ZENAPAX is contraindicated in patients with known hypersensitivity to Daclizumab or to any components of this product.
Brand Name: Zenapax
Generic Name: Daclizumab
Generic Name: Daclizumab
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
WebMD Resources
Health Extras
At Risk for Heart Disease?
Thanks to new technology, in just 15 seconds you can tell if you’re at risk for heart disease. Learn about this new tool. See more WebMD Videos »
